Overview
IPSEY market data
Price History
No market bars yet for IPSEY. This page will populate once the next provider sweep lands.
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for IPSEY. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Ipsen - Déclaration rectificative corrigeant la déclaration mensuelle du nombre total d'actions et de droits de vote au 30 juin 2026Globenewswire Inc · Jul 22, 2026, 4:30 PM
Ipsen - Corrective statement amending the monthly disclosure of the total number of shares and voting rights as of June 30, 2026Globenewswire Inc · Jul 22, 2026, 4:30 PM
IPSEN - Buy-back programme - Art 5 of MAR - Week 28 - 2026Globenewswire Inc · Jul 15, 2026, 4:15 PM
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine xx - 2025Globenewswire Inc · Jul 15, 2026, 4:15 PM
GENFIT: Positive Phase 1b Data with GNS561 in Combination Therapy in Heavily Pretreated Patients with CholangiocarcinomaGlobenewswire Inc · Jun 23, 2026, 4:15 PM
GENFIT : Données positives de Phase 1b obtenues avec GNS561 en combinaison, dans une population de patients atteints de cholangiocarcinome lourdement prétraitésGlobenewswire Inc · Jun 23, 2026, 4:15 PM
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 25 - 2026Globenewswire Inc · Jun 22, 2026, 4:15 PM
IPSEN - Buy-back programme - Art 5 of MAR - Week 25 - 2026Globenewswire Inc · Jun 22, 2026, 4:15 PM
Ipsen announces late-breaking data from first head-to-head study comparing Dysport® and Botox® in adults with upper limb spasticityGlobenewswire Inc · May 19, 2026, 7:15 PM
Ipsen annonce des données « late-breaking » issues de la première étude comparative directe entre Dysport® et Botox® chez des adultes atteints de spasticité du membre supérieurGlobenewswire Inc · May 19, 2026, 7:15 PM